Study - 医索

找到约 174 条结果

柳叶刀子刊发布全球痛风数据：男性患病率是女性的3倍

2024年7月9日，《Lancet Rheumatology》（IF=15.0）发表了关于痛风的全球疾病负担研究（Global Burden of Disease Study 2021），结果显示，2020年，全球有5580万人患有痛风，男性痛风患病率是女性的3.26倍。预计到2050年，痛风.....

学术资讯 - 临床医学

Randomized phase lllll trial of gemcitabine plusnab-paclitaxel versus. concurrentchemoradiotherapy with S-1 as neoadjuvanttreatment for borderline resectable pancreaticcancerGABARNANCE study

医客学院 - 会议报告集

Phasel study of C-CAR031, aGPc3-specificTGFBRllDN armored autologous CAR-T, inpatients with advanced hepatocellularcarcinoma(Hcc)

医客学院 - 会议报告集

Phase ll study of sitravatinib in combination withtislelizumab in patients with advanced biliary tractcancer who have failed to at least 1 prior systemictreatment

医客学院 - 会议报告集

NCIETCTN 10476 A Randomized, Phase 2 Study ofcombination Atezolizumab and Varlilumab(CDX-1127) withor without addition of Cobimetinib in Previously TreatedUnresectable Biliary Tract Cancer

医客学院 - 会议报告集

International, open-label phase 2 study of regorafenibplus pembrolizumab in patients with advancedhepatocellular carcinoma previously treated withimmune checkpoint inhibitors

医客学院 - 会议报告集

A randomized phase ll study of gemcitapine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, andiposomal irinotecan in older patients with treatment-naivemetastatic pancreatic cance

医客学院 - 会议报告集

A phase lll study of peri-operative nivolumab and ipilimumab inpatients with iocoregionai esophageai and qastroesophagealjunction adenocarcinoma-results of the neoadjuvant pathologiccomplete r

医客学院 - 会议报告集

TBCRC 048(0laparib Expanded) Expansion cohortsPhase ll study of olaparib monotherapy in metastatic breast cancer(MBC) patients with germline(g) mutations in PALB2 orsomatic(s) mutations in BRCA1 O

医客学院 - 会议报告集

Primary results from PATRICIA Cohort c (SOLTI-1303)a randomized phase ll study evaluating palbociclib withtrastuzumab and endocrine therapy in pretreated HER2.positive and PAM50 luminal advanced b

医客学院 - 会议报告集

首页
上一页
1
2
3
4
5
...
17
18
下一页
尾页

今日实时热搜